531762 Stock Overview
Engages in the manufacture and sale of ayurvedic products in India.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Unjha Formulations Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹35.04 |
| 52 Week High | ₹34.99 |
| 52 Week Low | ₹14.85 |
| Beta | 0.28 |
| 11 Month Change | 29.78% |
| 3 Month Change | 26.18% |
| 1 Year Change | 94.67% |
| 33 Year Change | 266.91% |
| 5 Year Change | 336.36% |
| Change since IPO | 204.17% |
Recent News & Updates
Recent updates
Shareholder Returns
| 531762 | IN Personal Products | IN Market | |
|---|---|---|---|
| 7D | 19.9% | 0.6% | 1.8% |
| 1Y | 94.7% | 8.1% | 36.8% |
Return vs Industry: 531762 exceeded the Indian Personal Products industry which returned 8.1% over the past year.
Return vs Market: 531762 exceeded the Indian Market which returned 36.8% over the past year.
Price Volatility
| 531762 volatility | |
|---|---|
| 531762 Average Weekly Movement | 7.5% |
| Personal Products Industry Average Movement | 4.4% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in IN Market | 9.4% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 531762's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: 531762's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 17 | Kruti Patel | www.unjhaformulations.com |
Unjha Formulations Limited engages in the manufacture and sale of ayurvedic products in India. It offers sat-isabgol and isabgo husk formulation in elaichi flavor under the Anchor name; and isabgol powder in orange flavor under the Fibron and Fibron SF names. The company also exports its products.
Unjha Formulations Limited Fundamentals Summary
| 531762 fundamental statistics | |
|---|---|
| Market cap | ₹142.75m |
| Earnings (TTM) | ₹7.95m |
| Revenue (TTM) | ₹186.96m |
19.7x
P/E Ratio0.8x
P/S RatioIs 531762 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 531762 income statement (TTM) | |
|---|---|
| Revenue | ₹186.96m |
| Cost of Revenue | ₹178.91m |
| Gross Profit | ₹8.05m |
| Other Expenses | ₹95.00k |
| Earnings | ₹7.95m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 08, 2024
| Earnings per share (EPS) | 1.78 |
| Gross Margin | 4.31% |
| Net Profit Margin | 4.25% |
| Debt/Equity Ratio | 0% |
How did 531762 perform over the long term?
See historical performance and comparison